SARS-CoV-2 neutralising antibodies in dogs and cats in the United Kingdom. (2021)
Attributed to:
Exploiting glycosylation against COVID-19
funded by
BBSRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1016/j.crviro.2021.100011
PubMed Identifier: 34377997
Publication URI: http://europepmc.org/abstract/MED/34377997
Type: Journal Article/Review
Volume: 2
Parent Publication: Current research in virological science
ISSN: 2666-478X